AKT1 and breast carcinoma: In breast cancer, exosomal miR-27a-3p was used as an intervention target to inhibit PD-L1 expression in macrophages, and to block the activation of the PTEN-AKT/PI3K pathway to inhibit immune escape in breast cancer cells [37].